{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:36:52Z","timestamp":1783388212299,"version":"3.54.6"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Autoimmune hepatitis (AIH) is a chronic inflammatory disease that can progress to cirrhosis and liver failure. While various biomarkers have been associated with AIH progression and prognosis, their specific roles in diagnosing, predicting, and managing cirrhosis, particularly in compensated cirrhosis, remain unclear. Accurately predicting 2-year survival and clinical outcomes for patients with compensated cirrhosis is a critical challenge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study analyzed clinical data from non-cirrhotic and cirrhotic AIH patients to identify factors influencing cirrhosis development and prognosis. Serum and nutritional indices were compared between groups with differing prognoses. The diagnostic efficacy of TSP-1, Gal-3, Cys-C, AIb, and PA was evaluated in compensated cirrhosis patients, and their prognostic value was validated using linear regression and Cox proportional hazards models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>No significant differences in gender, age, BMI, hypertension, diabetes history, or AMA positivity were observed between the non-cirrhotic AIH and cirrhotic AIH groups. However, TBil levels were significantly higher, and CD38 and IL-22 levels were significantly lower in the cirrhosis group. Multivariate logistic regression identified elevated TBil and reduced CD38 and IL-22 levels were associated with increased cirrhosis risk. Prognosis analysis revealed that patients with good outcomes had significantly lower TSP-1, Gal-3, and Cys-C levels and higher AIb and PA levels than those with poor outcomes. Cox proportional hazards modeling identified TSP-1, Gal-3, and Cys-C as independent risk factors and AIb and PA as protective factors influencing 2-year survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study underscores the critical roles of TBil, CD38, and IL-22 in cirrhosis development among AIH patients and validates the diagnostic and prognostic significance of TSP-1, Gal-3, Cys-C, AIb, and PA in compensated cirrhosis. These biomarkers facilitate early risk identification and inform clinical decision-making, contributing to improved management and outcomes for AIH patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1564107","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T05:35:10Z","timestamp":1746768910000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic and prognostic biomarkers in autoimmune hepatitis-associated cirrhosis: insights into TBil, CD38, IL-22, TSP-1, GAL-3, and Cyc-C"],"prefix":"10.3389","volume":"12","author":[{"given":"Jiani","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caijie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e0112722","DOI":"10.1128\/msystems.01127-22","article-title":"A novel synbiotic alleviates autoimmune hepatitis by modulating the gut microbiota-liver Axis and inhibiting the hepatic TLR4\/NF-\u03baB\/NLRP3 signaling pathway","volume":"8","author":"Kang","year":"2023","journal-title":"mSystems"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.3390\/jcm12051979","article-title":"Autoimmune hepatitis and fibrosis","volume":"12","author":"Pellicano","year":"2023","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1007\/s10238-023-01128-8","article-title":"Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives","volume":"23","author":"Villani","year":"2023","journal-title":"Clin Exp Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"101231","DOI":"10.1016\/j.mam.2023.101231","article-title":"Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies","volume":"95","author":"Parola","year":"2024","journal-title":"Mol Asp Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.3748\/wjg.v20.i10.2564","article-title":"Immune dysfunction in cirrhosis","volume":"20","author":"Sipeki","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9437043","article-title":"Autoimmune hepatitis-immunologically triggered liver pathogenesis-diagnostic and therapeutic strategies","volume":"2019","author":"Sucher","year":"2019","journal-title":"J Immunol Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e0269","DOI":"10.1097\/HC9.0000000000000269","article-title":"CD4+ T-cell subsets in autoimmune hepatitis: a review","volume":"7","author":"Chen","year":"2023","journal-title":"Hepatol Commun"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"AGA clinical practice update: diagnosis and Management of Nonalcoholic Fatty Liver Disease in lean individuals: expert review","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000347211","article-title":"Autoimmune hepatitis","volume":"31","author":"Strassburg","year":"2013","journal-title":"Dig Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.jceh.2022.04.021","article-title":"Overview of complications in cirrhosis","volume":"12","author":"Premkumar","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e0458","DOI":"10.1097\/HC9.0000000000000458","article-title":"Autoimmune hepatitis: current and future therapies","volume":"8","author":"Reau","year":"2024","journal-title":"Hepatol Commun."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1007\/s10620-021-06989-1","article-title":"Patients with autoimmune hepatitis report lower lifetime coffee consumption","volume":"67","author":"Lammert","year":"2022","journal-title":"Dig Dis Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"bcr0120125494","DOI":"10.1136\/bcr-01-2012-5494","article-title":"Exacerbation of AIH in a patient with an AIH\/systemic sclerosis overlap syndrome and pulmonary arterial hypertension treated with the endothelin-1 receptor antagonist sitaxentan","volume":"2012","author":"Klein","year":"2012","journal-title":"BMJ Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"7815","DOI":"10.1007\/s11033-023-08666-0","article-title":"Biomarkers of liver diseases","volume":"50","author":"Tamber","year":"2023","journal-title":"Mol Biol Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.dld.2017.06.010","article-title":"Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases","volume":"49","author":"Di Sabatino","year":"2017","journal-title":"Dig Liver Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/hepr.12787","article-title":"Role of thrombospondin 1 in liver diseases","volume":"47","author":"Li","year":"2017","journal-title":"Hepatol Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"7578","DOI":"10.1038\/s41467-022-35334-x","article-title":"Intracellular galectin-3 is a lipopolysaccharide sensor that promotes glycolysis through mTORC1 activation","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s43066-022-00231-x","article-title":"Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus","volume":"12","author":"Assem","year":"2022","journal-title":"Egypt Liver J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"876293","DOI":"10.3389\/fmed.2022.876293","article-title":"What makes cirrhosis irreversible?-consideration on structural changes","volume":"9","author":"Dezs\u0151","year":"2022","journal-title":"Front Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1177\/03915603231216191","article-title":"Minimally invasive connective water vapor energy method for benign prostatic hyperplasia","volume":"91","author":"\u00c7ak\u0131ro\u011flu","year":"2024","journal-title":"Urologia"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/j.jhep.2021.01.025","article-title":"Sarcopenia and frailty in decompensated cirrhosis","volume":"75","author":"Tandon","year":"2021","journal-title":"J Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMc2314292","article-title":"Liver transplantation","volume":"390","author":"Kappe","year":"2024","journal-title":"N Engl J Med"},{"key":"ref25","first-page":"757","article-title":"Thrombospondin-1 (TSP-1) and TSP-1-derived heparin-binding peptides induce promyelocytic leukemia cell differentiation and apoptosis","volume":"25","author":"Bruel","year":"2005","journal-title":"Anticancer Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"100193","DOI":"10.1016\/j.jhepr.2020.100193","article-title":"Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease","volume":"3","author":"Gwag","year":"2020","journal-title":"JHEP Rep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"107618","DOI":"10.1016\/j.intimp.2021.107618","article-title":"Targeting TSP-1 decreased periodontitis by attenuating extracellular matrix degradation and alveolar bone destruction","volume":"96","author":"Liu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.7150\/thno.84236","article-title":"Tsp-1+ microglia attenuate retinal neovascularization by maintaining the expression of Smad3 in endothelial cells through exosomes with decreased miR-27a-5p","volume":"13","author":"Luo","year":"2023","journal-title":"Theranostics"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jid.2019.01.011","article-title":"Thrombospondin-1 is a major activator of TGF-\u03b2 signaling in recessive dystrophic epidermolysis bullosa fibroblasts","volume":"139","author":"Atanasova","year":"2019","journal-title":"J Invest Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/ijmm.2017.3311","article-title":"Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (review)","volume":"41","author":"Dong","year":"2018","journal-title":"Int J Mol Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.3390\/cells10113047","article-title":"Novel Galectin-3 roles in neurogenesis, inflammation and neurological diseases","volume":"10","author":"Soares","year":"2021","journal-title":"Cells"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/biom10050798","article-title":"Galectin-3: roles in neurodevelopment, neuroinflammation, and behavior","volume":"10","author":"Srejovic","year":"2020","journal-title":"Biomol Ther"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1590\/abd1806-4841.20198426","article-title":"Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives","volume":"94","author":"Pasmatzi","year":"2019","journal-title":"An Bras Dermatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"102622","DOI":"10.1016\/j.jbc.2022.102622","article-title":"Chimeric galectin-3 and collagens: biomarkers and potential therapeutic targets in fibroproliferative diseases","volume":"298","author":"Nangia-Makker","year":"2022","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5414\/CP204432","article-title":"Factors influencing glomerular filtration rate as estimated using preoperative creatinine and cystatin C levels","volume":"61","author":"Nishimura","year":"2023","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1530\/EJE-15-0341","article-title":"Estimated glomerular filtration rate by serum cystatin C correlates with cardiometabolic parameters in patients with primary hyperparathyroidism","volume":"173","author":"Ermetici","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(22)02612-5","article-title":"Malnutrition in older adults","volume":"401","author":"Dent","year":"2023","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0022-4804(87)90172-7","article-title":"Effect of sepsis and starvation on amino acid uptake in skeletal muscle","volume":"42","author":"Warner","year":"1987","journal-title":"J Surg Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","article-title":"Grifols chair and European Foundation for the Study of chronic liver failure (EF-Clif). The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis","volume":"74","author":"Arroyo","year":"2021","journal-title":"J Hepatol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1564107\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T05:35:11Z","timestamp":1746768911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1564107\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":39,"alternative-id":["10.3389\/fmed.2025.1564107"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1564107","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"article-number":"1564107"}}